معرفی
Marcus Söderström is a Research Fellow in the Department of Medicinal Chemistry at Uppsala University, Sweden, specializing in Preparative Medicinal Chemistry. His work centers on developing innovative synthetic methodologies with direct applications in drug discovery, leveraging expertise in sulfur and fluorine chemistry to create novel bioactive compounds.
His research spans Medicinal Chemistry, Organic Chemistry, and Synthetic Chemistry, with specialized focus on Fluorine Chemistry, Chemical Biology, and Heterocyclic Chemistry. Key contributions include designing thiomethylation techniques for nitrogen heterocycles, defluorinative functionalization strategies for trifluoromethylarenes, and enzyme inhibitors targeting insulin regulated aminopeptidase (IRAP). His approach integrates molecular modeling with synthetic validation to optimize compound efficacy.
Analysis of his 2019-2025 publications reveals a dominant trend in sulfur-based synthetic chemistry, particularly using BF3·SMe2 reagents for thioacetalation, Friedel-Crafts reactions, and diazomethane generation. This work bridges fundamental organic synthesis with medicinal applications, emphasizing environmentally conscious methodologies like base-free reactions and low-temperature protocols for improved selectivity and safety.
No scientific awards were documented in the source material.
Details regarding graduate student mentorship and externally funded research grants were not specified, though his collaborative publications suggest active engagement with interdisciplinary teams including computational chemists and pharmacologists.
Dr. Söderström operates within Uppsala University's Biomedical Centre (BMC), utilizing state-of-the-art facilities in the Preparative Medicinal Chemistry division for multi-step synthesis, purification, and biological testing of novel compounds targeting unmet medical needs.
